2022 Consensus Statement on Minimally Invasive Procedures for Benign and Malignant Thyroid Lesions

ASEM 文献综述

Official American Association of Clinical Endocrinology document (2022) on “2022 Consensus Statement on Minimally Invasive Procedures for Benign and Malignant Thyroid Lesions”. This consensus statement provides information on novel minimally invasive therapeutic interventions for thyroid malignancies such as percutaneous ethanol injection and thermal ablation. The statement summarizes existing knowledge and provides guidance on indications, techniques, complications, and follow-ups for care of patients with benign and malignant thyroid lesions. DOI: 10.1016/j.eprac.2022.02.011.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。